Press Room
Role of lymph node dissection in RCC
02/29/2012
Controversy exists over whether lymph node dissection (LND) simply provides improved staging or whether removal of pathologic nodes offers a therapeutic advantage.
Axitinib Tops Sorafenib as Second-Line RCC Treatment
02/29/2012
Axitinib treatment led to a significant and clinically meaningful improvement in progression-free survival compared with sorafenib in patients with treatment-refractory renal-cell carcinoma...
Study: Bevacizumab in Combination With Low-Dose-Interferon
02/28/2012
This single arm study will assess progression free survival, tumor response and safety of Avastin in combination with interferon alfa-2a (IFN) as first line treatment in patients with metastatic clear cell renal cell carcinoma.
Partial Kidney Removal Also Gives Long-Term Survival: Study
02/24/2012
The study has revealed that usually the kidney cancer patients needing surgery have their whole kidney taken out but the patients can healthily survive long-term even if just a part of the organ is removed.
Pre-Surgical Sutent in Renal Cell Carcinoma
02/24/2012
The goal of this clinical research study is to learn if Sutent® (sunitinib malate), given before surgery, can help control renal cell carcinoma. The safety of sunitinib malate will also be studied.
IL-7 Treating Patients With Metastatic Kidney Cancer
02/24/2012
This phase I trial is studying the side effects and best dose of interleukin-7 in treating patients with metastatic melanoma or locally advanced or metastatic kidney cancer.
PHOTOS: Living With Kidney Cancer
02/21/2012
Meet other families that are dealing with renal cancers at www.KidneyCancer.ME
Why the UK Is Ditching Socialized Medicine
02/21/2012
...even under optimum conditions, people suffering from afflictions such as heart disease and cancer will face more than a five-and-a-half month wait before getting the treatment they need.
News Feed| Powered by NeonCRM |